Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy

L Adhikary, Fiona YF Chow, David J Nikolic-Paterson, Cosimo Stambe, John P Dowling, Robert C Atkins, Greg H Tesch

Research output: Contribution to journalArticleResearchpeer-review

164 Citations (Scopus)


Aims/hypothesis. Inflammation and fibrosis are pathological mechanisms that are partially regulated by cell signalling through the p38 mitogen-activated protein kinase (MAPK) pathway. Elements of the diabetic milieu such as high glucose and advanced glycation endproducts induce activation of this pathway in renal cells. Therefore, we examined whether p38 MAPK signalling is associated with the development of human and experimental diabetic nephropathy. Methods. Immunostaining identified phosphorylated (active) p38 MAPK in human biopsies with no abnormality (n=6) and with Type 2 diabetic nephropathy (n=12). Changes in kidney levels of phosphorylated p38 were assessed by immunostaining and western blotting in mice with streptozotocin-induced Type 1 diabetes that had been killed after 0.5, 2, 3, 4 and 8 months, and in Type 2 diabetic db/db mice at 2, 4, 6 and 8 months of age.
Original languageEnglish
Pages (from-to)1210 - 1222
Number of pages13
Issue number7
Publication statusPublished - 2004

Cite this